Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction to: Relevance of biomarkers across different neurodegenerative diseases.
Ehrenberg AJ, Khatun A, Coomans E, Betts MJ, Capraro F, Thijssen EH, Senkevich K, Bharucha T, Jafarpour M, Young PNE, Jagust W, Carter SF, Lashley T, Grinberg LT, Pereira JB, Mattsson-Carlgren N, Ashton NJ, Hanrieder J, Zetterberg H, Schöll M, Paterson RW. Ehrenberg AJ, et al. Alzheimers Res Ther. 2020 Jun 9;12(1):71. doi: 10.1186/s13195-020-00637-y. Alzheimers Res Ther. 2020. PMID: 32517788 Free PMC article.
Clinical effects of Lewy body pathology in cognitively impaired individuals.
Quadalti C, Palmqvist S, Hall S, Rossi M, Mammana A, Janelidze S, Dellavalle S, Mattsson-Carlgren N, Baiardi S, Stomrud E, Hansson O, Parchi P. Quadalti C, et al. Nat Med. 2023 Aug;29(8):1964-1970. doi: 10.1038/s41591-023-02449-7. Epub 2023 Jul 18. Nat Med. 2023. PMID: 37464058 Free PMC article.
Relevance of biomarkers across different neurodegenerative diseases.
Ehrenberg AJ, Khatun A, Coomans E, Betts MJ, Capraro F, Thijssen EH, Senkevich K, Bharucha T, Jafarpour M, Young PNE, Jagust W, Carter SF, Lashley T, Grinberg LT, Pereira JB, Mattsson-Carlgren N, Ashton NJ, Hanrieder J, Zetterberg H, Schöll M, Paterson RW. Ehrenberg AJ, et al. Alzheimers Res Ther. 2020 May 13;12(1):56. doi: 10.1186/s13195-020-00601-w. Alzheimers Res Ther. 2020. PMID: 32404143 Free PMC article. Review.
Comparing progression biomarkers in clinical trials of early Alzheimer's disease.
Cullen NC, Zetterberg H, Insel PS, Olsson B, Andreasson U; Alzheimer’s Disease Neuroimaging Initiative; Blennow K, Hansson O, Mattsson-Carlgren N. Cullen NC, et al. Ann Clin Transl Neurol. 2020 Sep;7(9):1661-1673. doi: 10.1002/acn3.51158. Epub 2020 Aug 11. Ann Clin Transl Neurol. 2020. PMID: 32779869 Free PMC article.
Plasma phosphorylated tau181 and neurodegeneration in Alzheimer's disease.
Hansson O, Cullen N, Zetterberg H; Alzheimer’s Disease Neuroimaging Initiative; Blennow K, Mattsson-Carlgren N. Hansson O, et al. Ann Clin Transl Neurol. 2021 Jan;8(1):259-265. doi: 10.1002/acn3.51253. Epub 2020 Nov 29. Ann Clin Transl Neurol. 2021. PMID: 33249783 Free PMC article.
The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease.
Simrén J, Leuzy A, Karikari TK, Hye A, Benedet AL, Lantero-Rodriguez J, Mattsson-Carlgren N, Schöll M, Mecocci P, Vellas B, Tsolaki M, Kloszewska I, Soininen H, Lovestone S, Aarsland D; AddNeuroMed consortium; Hansson O, Rosa-Neto P, Westman E, Blennow K, Zetterberg H, Ashton NJ. Simrén J, et al. Alzheimers Dement. 2021 Jul;17(7):1145-1156. doi: 10.1002/alz.12283. Epub 2021 Jan 25. Alzheimers Dement. 2021. PMID: 33491853 Free PMC article.
2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.
Leuzy A, Ashton NJ, Mattsson-Carlgren N, Dodich A, Boccardi M, Corre J, Drzezga A, Nordberg A, Ossenkoppele R, Zetterberg H, Blennow K, Frisoni GB, Garibotto V, Hansson O. Leuzy A, et al. Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2121-2139. doi: 10.1007/s00259-021-05258-7. Epub 2021 Mar 5. Eur J Nucl Med Mol Imaging. 2021. PMID: 33674895 Free PMC article. Review.
112 results